HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Proglumid
ProM · kxm · xyde · 242dl · cr242 · milid · nulsa · w5219
Identifikatoren & physikalische Daten
| CAS No. | 6620-60-6 |
|---|---|
| Summenformel | C18H26N2O4 |
| Durchschnittliche Molmasse | 334,4 g/mol |
| Monoisotopische Masse | 334,18925731 g/mol |
| SMILES | CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1 |
| InChIKey | DGMKFQYCZXERLX-UHFFFAOYSA-N |
| PubChem CID | 4922 |
| ChEMBL | CHEMBL316561 |
| ChEBI | CHEBI:32058 |
| EC No. | 229-567-4 |
| DTXSID | DTXSID7023516 |
| Lokaler Name | Proglumid |
Chemische & physikalische Eigenschaften
| XLogP | 2,4 |
|---|---|
| Polarare Oberfläche (TPSA) | 86,7 |
| H-Brücken-Donoren | 2 |
| H-Brücken-Akzeptoren | 4 |
| Frei drehbare Bindungen | 10 |
| Schwere Atome | 24 |
| Formalladung | 0 |
| Komplexität | 413 |
| Human Drugs | Pharmaceuticals |
| Collision Cross Section | 181.1 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]186.48 Ų [M+K]+ [CCS Type: TW |
| Schmelzpunkt | 148-150°C |
| Siedepunkt | 471.21°C (rough estimate) |
| Dichte | 1.1944 (rough estimate) |
| Brechungsindex | 1.5700 (estimate) |
| Lagerbedingungen | Keep in dark place,Sealed in dry,Room Temperature |
| Löslichkeit | DMSO (Slightly), Methanol (Slightly) |
| Aggregatzustand | Solid |
| pKa (Säurekonstante) | 4.51±0.10(Predicted) |
| Farbe | Crystals |
| InChI | InChI=1S/C18H26N2O4/c1-3-12-20(13-4-2)18(24)15(10-11-16(21)22)19-17(23)14-8-6-5-7-9-14/h5-9,15H,3-4,10-13H2,1-2H3,(H,19,23)(H,21,22) |
| InChIKey | DGMKFQYCZXERLX-UHFFFAOYSA-N |
| SMILES | C(O)(=O)CCC(NC(=O)C1=CC=CC=C1)C(N(CCC)CCC)=O |
| CAS Datenbank | 6620-60-6(CAS DataBase Reference) |
| EPA chemische Informationen | Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo- (6620-60-6) |
Sicherheit & Vorschriften
| GHS-Einstufung | This chemical does not meet GHS hazard criteria for 100% (3 of 3) of all reports.Not ClassifiedAggregated GHS information provided per 3 reports by companies from 1 notifications to the ECHA C&L Inventory. |
|---|---|
| Regulatorische Informationen | REACH registered substance: Proglumide (EC: 229-567-4) |
| Weitere Sicherheitsinformationen | IMAP assessments - Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (.+-.)-: Human health tier I assessment |
| Hazard Classes and Categories | Not Classified |
| Toxizität | LD50 in mice (mg/kg): 2211-2649 i.v.7350-8861 orally (Rovati) |
Anwendungen & Verwendung
Beschreibung
Proglumide (Milid) is a drug that inhibits gastrointestinal motility and reduces gastric secretions. It acts as a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. It was used mainly in the treatment of stomach ulcers, although it has now been largely replaced by newer drugs for this application.Proglumide is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide selective blocks CCK’s effects in the central nervous system (CNS). Proglumide has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide also has antiepileptic and antioxidant activities.
Verwenden
Anticholinergic.